Objective The purpose of this article is to provide a systematic overview of the literature on
adrenal suppression and Cushing's syndrome secondary to an interaction between …

The purpose of this review is to provide the clinician with an update on the potential adverse
effects caused by the inhaled corticosteroids (ICSs). The systemic effects of ICSs are a result …

Rationale and Objectives: Lung cancer is a frequent cause of death among patients with
chronic obstructive pulmonary disease (COPD). We examined whether the use of inhaled …

Mitogen-activated protein (MAP) kinases are critical mediators of innate immune responses.
In response to lipopolysaccharide (LPS), MAP kinases are rapidly activated and play an …

Asthma is a chronic inflammatory disease characterized by symptoms of cough, dyspnea,
chest tightness, and wheeze. Inhaled corticosteroids (ICS) have been recommended as …

Asthma is characterized by inflammation in the lung and glucocorticoids (GCs) are the most
clinically effective treatment available. The success of chronic GC therapy for asthma stems …

Objective: To review the basis for the estimated comparative daily dosages of inhaled
corticosteroids for children and adults that are presented in the National Heart, Lung, and …

Patients with chronic obstructive pulmonary disease (COPD) are frequently treated with
inhaled corticosteroids (ICS). However, the impact of ICS use on fracture risk remains …

The vasoconstrictive efficacies of glucocorticosteroids (GS) are usually compared by the
McKenzie skin-blanching test and taken as an index of relative potency. The rationale for the …

There has been increasing concern in the medical literature about the safety of inhaled and
nasal corticosteroids, since many patients, both adults and children, are increasingly …